Johnson & Johnson (JNJ) is rated a Hold: defensive quality, DCF valuation, easing litigation, and dividend outlook—see key ...
Commercial vessels are deploying high-tech sensors to map a shifting sea, providing critical data for scientists and some help for the industry. By Eric Niiler and Tristan Spinski The panel voted to ...
Apr. 3, 2026 A new gene therapy is giving people born deaf the chance to hear, often within just weeks. In a small but groundbreaking study, researchers delivered a working copy of a key hearing gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results